Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease.

MLA

Mao, Zhongping Lily, and Nishit B. Modi. “Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease.” Journal of Clinical Pharmacology, vol. 56, no. 8, Aug. 2016, pp. 974–82. EBSCOhost, https://doi.org/10.1002/jcph.683.

APA

Mao, Z. L., & Modi, N. B. (2016). Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease. Journal of Clinical Pharmacology, 56(8), 974–982. https://doi.org/10.1002/jcph.683

Chicago

Mao, Zhongping Lily, and Nishit B Modi. 2016. “Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease.” Journal of Clinical Pharmacology 56 (8): 974–82. doi:10.1002/jcph.683.